RANI THERAPEUTICS HOLDINGS INC. - CLASS A COMMON
2.4700
13-11月-24 16:45:00
15 分の遅延
株式
-0.1000
-3.89%
本日の幅
2.4500 - 2.5931
ISIN
N/A
ソース
NASDAQ
-
12 10 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
18 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies
07 9 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in September Investor Conferences
06 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
11 8 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in August Investor Conferences
04 8 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
21 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
08 6 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105
05 6 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the Jefferies Healthcare Conference
01 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
31 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics Appoints Kate McKinley as Chief Business Officer
24 5 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update
10 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ
25 4 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
11 4 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
22 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
16 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment
09 1 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update
05 1 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study
06 12 2022 16:05:00 提供 Nasdaq GlobeNewswire